175 related articles for article (PubMed ID: 12490784)
21. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic islet allograft in spleen with immunosuppression with cyclosporine. Experimental model in dogs.
Waisberg J; Neff CB; Waisberg DR; Germini D; Gonçalves JE; Zanotto A; Speranzini MB
Acta Cir Bras; 2011; 26 Suppl 2():57-64. PubMed ID: 22030816
[TBL] [Abstract][Full Text] [Related]
23. Effect of cyclosporine on established islet autografts.
Basadonna G; Kakizaki K; Merrell RC
J Surg Res; 1986 May; 40(5):450-4. PubMed ID: 3090372
[TBL] [Abstract][Full Text] [Related]
24. Effects of cyclosporine on insulin secretion and insulin sensitivity in dogs with intrasplenic islet autotransplants.
Kneteman NM; Marchetti P; Tordjman K; Bier DM; Santiago JV; Swanson CJ; Olack BJ; Scharp DW
Surgery; 1992 Apr; 111(4):430-7. PubMed ID: 1557689
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppression for pancreatic islet transplantation.
Berney T; Buhler LH; Majno P; Mentha G; Morel P
Transplant Proc; 2004 Mar; 36(2 Suppl):362S-366S. PubMed ID: 15041369
[TBL] [Abstract][Full Text] [Related]
26. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.
Hirshberg B; Rother KI; Digon BJ; Lee J; Gaglia JL; Hines K; Read EJ; Chang R; Wood BJ; Harlan DM
Diabetes Care; 2003 Dec; 26(12):3288-95. PubMed ID: 14633816
[TBL] [Abstract][Full Text] [Related]
27. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation.
Lopez-Talavera JC; Garcia-Ocaña A; Sipula I; Takane KK; Cozar-Castellano I; Stewart AF
Endocrinology; 2004 Feb; 145(2):467-74. PubMed ID: 14551233
[TBL] [Abstract][Full Text] [Related]
28. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.
van Duijnhoven EM; Christiaans MHL; Boots JMM; Nieman FHM; Wolffenbuttel BHR; van Hooff JP
J Am Soc Nephrol; 2002 Jan; 13(1):213-220. PubMed ID: 11752040
[TBL] [Abstract][Full Text] [Related]
29. Vascularized islet-cell transplantation in miniature swine. I. Preparation of vascularized islet kidneys.
Kumagai N; O'Neil JJ; Barth RN; LaMattina JC; Utsugi R; Moran SG; Yamamoto S; Vagefi PA; Kitamura H; Kamano C; Sachs DH; Yamada K
Transplantation; 2002 Nov; 74(9):1223-30. PubMed ID: 12451257
[TBL] [Abstract][Full Text] [Related]
30. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin.
Rolles K; Davidson BR; Burroughs AK
Transplantation; 1999 Oct; 68(8):1195-8. PubMed ID: 10551650
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
Kenyon NS; Fernandez LA; Lehmann R; Masetti M; Ranuncoli A; Chatzipetrou M; Iaria G; Han D; Wagner JL; Ruiz P; Berho M; Inverardi L; Alejandro R; Mintz DH; Kirk AD; Harlan DM; Burkly LC; Ricordi C
Diabetes; 1999 Jul; 48(7):1473-81. PubMed ID: 10389857
[TBL] [Abstract][Full Text] [Related]
32. The effect of prednisone on pancreatic islet autografts in dogs.
Zeng Y; Ricordi C; Lendoire J; Carroll PB; Alejandro R; Bereiter DR; Tzakis A; Starzl TE
Surgery; 1993 Jan; 113(1):98-102. PubMed ID: 8417496
[TBL] [Abstract][Full Text] [Related]
33. The metabolic response of intrasplenic islet autografts.
Merrell RC; Marincola F; Maeda M; Cobb L; Basadonna G
Surg Gynecol Obstet; 1985 Jun; 160(6):552-6. PubMed ID: 3923638
[TBL] [Abstract][Full Text] [Related]
34. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients.
Scharp DW; Lacy PE; Santiago JV; McCullough CS; Weide LG; Boyle PJ; Falqui L; Marchetti P; Ricordi C; Gingerich RL
Transplantation; 1991 Jan; 51(1):76-85. PubMed ID: 1987709
[TBL] [Abstract][Full Text] [Related]
35. Successful islet auto- and allotransplantation in diabetic pigs.
Mellert J; Hering BJ; Liu X; Brandhorst D; Brandhorst H; Brendel M; Ernst E; Gramberg D; Bretzel RG; Hopt UT
Transplantation; 1998 Jul; 66(2):200-4. PubMed ID: 9701264
[TBL] [Abstract][Full Text] [Related]
36. Reversal of naturally occuring diabetes in primates by unmodified islet xenografts without chronic immunosuppression.
Thomas FT; Ricordi C; Contreras JL; Hubbard WJ; Jiang XL; Eckhoff DE; Cartner S; Bilbao G; Neville DM; Thomas JM
Transplantation; 1999 Mar; 67(6):846-54. PubMed ID: 10199733
[TBL] [Abstract][Full Text] [Related]
37. Free intraperitoneal islet autografts in pancreatectomized dogs--impact of islet purity and posttransplantation exogenous insulin.
Wahoff DC; Sutherland DE; Hower CD; Lloveras JK; Gores PF
Surgery; 1994 Oct; 116(4):742-8; discussion 748-50. PubMed ID: 7940174
[TBL] [Abstract][Full Text] [Related]
38. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression.
Lanza RP; Butler DH; Borland KM; Staruk JE; Faustman DL; Solomon BA; Muller TE; Rupp RG; Maki T; Monaco AP
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11100-4. PubMed ID: 1763025
[TBL] [Abstract][Full Text] [Related]
39. Weaning of immunosuppression in liver transplant recipients.
Mazariegos GV; Reyes J; Marino IR; Demetris AJ; Flynn B; Irish W; McMichael J; Fung JJ; Starzl TE
Transplantation; 1997 Jan; 63(2):243-9. PubMed ID: 9020325
[TBL] [Abstract][Full Text] [Related]
40. Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans.
Kendall DM; Teuscher AU; Robertson RP
Diabetes; 1997 Jan; 46(1):23-7. PubMed ID: 8971076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
